These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35920071)

  • 1. Guanylyl cyclase C as a diagnostic and therapeutic target in colorectal cancer.
    Caspi A; Entezari AA; Crutcher M; Snook AE; Waldman SA
    Per Med; 2022 Sep; 19(5):457-472. PubMed ID: 35920071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer.
    Rappaport JA; Waldman SA
    Expert Rev Clin Pharmacol; 2020 Oct; 13(10):1125-1137. PubMed ID: 32945718
    [No Abstract]   [Full Text] [Related]  

  • 3. Guanylyl cyclase 2C (GUCY2C) in gastrointestinal cancers: recent innovations and therapeutic potential.
    Entezari AA; Snook AE; Waldman SA
    Expert Opin Ther Targets; 2021 May; 25(5):335-346. PubMed ID: 34056991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanylyl Cyclase C Hormone Axis at the Intersection of Obesity and Colorectal Cancer.
    Blomain ES; Merlino DJ; Pattison AM; Snook AE; Waldman SA
    Mol Pharmacol; 2016 Sep; 90(3):199-204. PubMed ID: 27251363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GUCY2C ligand replacement to prevent colorectal cancer.
    Blomain ES; Pattison AM; Waldman SA
    Cancer Biol Ther; 2016 Jul; 17(7):713-8. PubMed ID: 27104761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies.
    Flickinger JC; Rappaport JA; Barton JR; Baybutt TR; Pattison AM; Snook AE; Waldman SA
    Biomark Med; 2021 Feb; 15(3):201-217. PubMed ID: 33470843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.
    Aka AA; Rappaport JA; Pattison AM; Sato T; Snook AE; Waldman SA
    Expert Rev Clin Pharmacol; 2017 May; 10(5):549-557. PubMed ID: 28162021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanylyl cyclase C signaling axis and colon cancer prevention.
    Pattison AM; Merlino DJ; Blomain ES; Waldman SA
    World J Gastroenterol; 2016 Sep; 22(36):8070-7. PubMed ID: 27688649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer.
    Gibbons AV; Lin JE; Kim GW; Marszalowicz GP; Li P; Stoecker BA; Blomain ES; Rattan S; Snook AE; Schulz S; Waldman SA
    Cancer Res; 2013 Nov; 73(22):6654-66. PubMed ID: 24085786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention.
    Yarla NS; Gali H; Pathuri G; Smriti S; Farooqui M; Panneerselvam J; Kumar G; Madka V; Rao CV
    Semin Cancer Biol; 2019 Jun; 56():168-174. PubMed ID: 30189250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer.
    Wilson C; Lin JE; Li P; Snook AE; Gong J; Sato T; Liu C; Girondo MA; Rui H; Hyslop T; Waldman SA
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2328-37. PubMed ID: 25304930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.
    Weinberg DS; Lin JE; Foster NR; Della'Zanna G; Umar A; Seisler D; Kraft WK; Kastenberg DM; Katz LC; Limburg PJ; Waldman SA
    Cancer Prev Res (Phila); 2017 Jun; 10(6):345-354. PubMed ID: 28396341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer.
    Lisby AN; Flickinger JC; Bashir B; Weindorfer M; Shelukar S; Crutcher M; Snook AE; Waldman SA
    Expert Rev Precis Med Drug Dev; 2021; 6(2):117-129. PubMed ID: 34027103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers.
    Weinberg DS; Foster NR; Della'Zanna G; McMurray RP; Kraft WK; Pallotto A; Kastenberg DM; Katz LC; Henry CH; Moleski SM; Limburg PJ; Waldman SA
    Cancer Biol Ther; 2021 Dec; 22(10-12):544-553. PubMed ID: 34632925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing the intestinal GUCY2C tumor suppressor axis requires
    Pattison AM; Barton JR; Entezari AA; Zalewski A; Rappaport JA; Snook AE; Waldman SA
    Cancer Biol Ther; 2020 Sep; 21(9):799-805. PubMed ID: 32594830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APC-β-catenin-TCF signaling silences the intestinal guanylin-GUCY2C tumor suppressor axis.
    Blomain ES; Rappaport JA; Pattison AM; Bashir B; Caparosa E; Stem J; Snook AE; Waldman SA
    Cancer Biol Ther; 2020 May; 21(5):441-451. PubMed ID: 32037952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanylyl cyclase C in colorectal cancer: susceptibility gene and potential therapeutic target.
    Lin JE; Li P; Pitari GM; Schulz S; Waldman SA
    Future Oncol; 2009 May; 5(4):509-22. PubMed ID: 19450179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis.
    Lin JE; Colon-Gonzalez F; Blomain E; Kim GW; Aing A; Stoecker B; Rock J; Snook AE; Zhan T; Hyslop TM; Tomczak M; Blumberg RS; Waldman SA
    Cancer Res; 2016 Jan; 76(2):339-46. PubMed ID: 26773096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Guanylate Cyclase C-cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia.
    Rappaport JA; Waldman SA
    Front Oncol; 2018; 8():299. PubMed ID: 30131940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
    Cagir B; Gelmann A; Park J; Fava T; Tankelevitch A; Bittner EW; Weaver EJ; Palazzo JP; Weinberg D; Fry RD; Waldman SA
    Ann Intern Med; 1999 Dec; 131(11):805-12. PubMed ID: 10610624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.